Lauren Gilstrap
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Lauren Gilstrap has a total of 133 co-authors. Here are the top co-authors by number of shared publications:
Andrea M. Austin
Geisel School of Medicine at Dartmouth The Dartmouth Institute Hanover New Hampshire USA
5 shared publicationsJonathan S. Skinner
The Dartmouth Institute, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
5 shared publicationsBarbara Gladders
Dartmouth‐Hitchcock Medical Center The Dartmouth Institute Lebanon New Hampshire USA
4 shared publicationsAnna N. A. Tosteson
Geisel School of Medicine at Dartmouth The Dartmouth Institute Hanover New Hampshire USA
3 shared publicationsA. James O'MAlley
The Dartmouth Institute, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire
2 shared publicationsA. James O’mAlley
The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Hanover, USA
2 shared publications
Latest Publications
- Open Access
- 4 July 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (13) , e029758
Variation in Risk‐Standardized Acute Admission Rates Among Patients With Heart Failure in Accountable Care Organizations: Implications for Quality Measurement
Background: Accountable care organizations (ACOs) aim to improve health care quality and reduce costs, including among patients with heart failure (HF). However, variation across ACOs in admission rates for patients with HF and associated factors are not well described. Methods and Results: We identified Medicare fee‐for‐service beneficiaries with HF who were assigned to a Medicare Shared Savings Program ACO in 2017 and survived ≥30 days into 2018. We calculated risk‐standardized acute admission rates across ACOs, assigned ACOs to 1 of 3 performance categories, and examined associations between ACO characteristics and performance categories. Among 1 232 222 beneficiaries with HF, 283 795 (mean age, 81 years; 54% women; 86% White; 78% urban) were assigned to 1 of 467 Medicare Shared Savings Program ACOs. Across ACOs, the median risk‐standardized acute admission rate was 87 admissions per 100 people, ranging from 61 (minimum) to 109 (maximum) admissions per 100 beneficiaries. Compared to the overall average, 13% of ACOs performed better on risk‐standardized acute admission rates, 72% were no different, and 14% performed worse. Most ACOs with better performance had fewer Black beneficiaries and were not hospital affiliated. Most ACOs that performed worse than average were large, located in the Northeast, had a hospital affiliation, and had a lower proportion of primary care providers. Conclusions: Admissions are common among beneficiaries with HF in ACOs, and there is variation in risk‐standardized acute admission rates across ACOs. ACO performance was associated with certain ACO characteristics. Future studies should attempt to elucidate the relationship between ACO structure and characteristics and admission risk.
- 4 July 2023
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (13) , e029758
Open AccessVariation in Risk‐Standardized Acute Admission Rates Among Patients With Heart Failure in Accountable Care Organizations: Implications for Quality Measurement
Background: Accountable care organizations (ACOs) aim to improve health care quality and reduce costs, including among patients with heart failure (HF). However, variation across ACOs in admission rates for patients with HF and associated factors are not well described. Methods and Results: We identified Medicare fee‐for‐service beneficiaries with HF who were assigned to a Medicare Shared Savings Program ACO in 2017 and survived ≥30 days into 2018. We calculated risk‐standardized acute admission rates across ACOs, assigned ACOs to 1 of 3 performance categories, and examined associations between ACO characteristics and performance categories. Among 1 232 222 beneficiaries with HF, 283 795 (mean age, 81 years; 54% women; 86% White; 78% urban) were assigned to 1 of 467 Medicare Shared Savings Program ACOs. Across ACOs, the median risk‐standardized acute admission rate was 87 admissions per 100 people, ranging from 61 (minimum) to 109 (maximum) admissions per 100 beneficiaries. Compared to the overall average, 13% of ACOs performed better on risk‐standardized acute admission rates, 72% were no different, and 14% performed worse. Most ACOs with better performance had fewer Black beneficiaries and were not hospital affiliated. Most ACOs that performed worse than average were large, located in the Northeast, had a hospital affiliation, and had a lower proportion of primary care providers. Conclusions: Admissions are common among beneficiaries with HF in ACOs, and there is variation in risk‐standardized acute admission rates across ACOs. ACO performance was associated with certain ACO characteristics. Future studies should attempt to elucidate the relationship between ACO structure and characteristics and admission risk.
- 11 December 2022
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 29 (4) , 434-444
The Association Between Beta-blocker and Renin–Angiotensin System Inhibitor Use After Heart Failure With Reduced Ejection Fraction Hospitalization and Outcomes in Older Patients
- 11 December 2022
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 29 (4) , 434-444
The Association Between Beta-blocker and Renin–Angiotensin System Inhibitor Use After Heart Failure With Reduced Ejection Fraction Hospitalization and Outcomes in Older Patients
- Open Access
- 6 May 2022
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 9 (4) , 2719-2723
Opposing Forces of Cardiogenic Shock: Left Ventricular Outflow Obstruction, Severe Mitral Regurgitation, and Left Ventricular Dysfunction in Takotsubo Cardiomyopathy
Rates of stress (Takotsubo) cardiomyopathy have increased during the coronavirus pandemic due to social stressors, even in patients who are not infected with the virus. At times, Takotsubo cardiomyopathy (TC) may present as cardiogenic shock. Herein, we present a case during the pandemic of shock from TC secondary to left ventricular outflow tract obstruction (LVOTO), mitral regurgitation (MR), and left ventricular (LV) dysfunction. The contrasting management strategy of LVOTO, MR, and LV failure was cause for clinical challenge, and we highlight the balance of treating these opposing forces.
- 6 May 2022
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 9 (4) , 2719-2723
Open AccessOpposing Forces of Cardiogenic Shock: Left Ventricular Outflow Obstruction, Severe Mitral Regurgitation, and Left Ventricular Dysfunction in Takotsubo Cardiomyopathy
Rates of stress (Takotsubo) cardiomyopathy have increased during the coronavirus pandemic due to social stressors, even in patients who are not infected with the virus. At times, Takotsubo cardiomyopathy (TC) may present as cardiogenic shock. Herein, we present a case during the pandemic of shock from TC secondary to left ventricular outflow tract obstruction (LVOTO), mitral regurgitation (MR), and left ventricular (LV) dysfunction. The contrasting management strategy of LVOTO, MR, and LV failure was cause for clinical challenge, and we highlight the balance of treating these opposing forces.
- 27 April 2022
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 115 (5) , 315-330
Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis
- 27 April 2022
- Published by Elsevier in Archives of Cardiovascular Diseases
- Vol. 115 (5) , 315-330
Association of early electrical changes with cardiovascular outcomes in immune checkpoint inhibitor myocarditis
- Open Access
- 28 February 2022
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 79 (4) , 342-348
Trends in Mortality Rates Among Medicare Enrollees With Alzheimer Disease and Related Dementias Before and During the Early Phase of the COVID-19 Pandemic
In 2020, COVID-19 abruptly altered the delivery of health care and the daily operations of nursing facilities.1 Changes in health care delivery included a decrease in inpatient care2,3 and a transition of outpatient care to telehealth platforms.4 Changes in nursing facility operations included lockdowns and strict visitation procedures, resulting in social isolation for many residents.5-7 The association between those secondary changes related to the pandemic and patient outcomes, especially among vulnerable populations, has not been well described.
- 28 February 2022
- Published by American Medical Association (AMA) in JAMA Neurology
- Vol. 79 (4) , 342-348
Open AccessTrends in Mortality Rates Among Medicare Enrollees With Alzheimer Disease and Related Dementias Before and During the Early Phase of the COVID-19 Pandemic
In 2020, COVID-19 abruptly altered the delivery of health care and the daily operations of nursing facilities.1 Changes in health care delivery included a decrease in inpatient care2,3 and a transition of outpatient care to telehealth platforms.4 Changes in nursing facility operations included lockdowns and strict visitation procedures, resulting in social isolation for many residents.5-7 The association between those secondary changes related to the pandemic and patient outcomes, especially among vulnerable populations, has not been well described.
- 1 December 2021
- Published by Clinical Care Targeted Communications Group, LLC in The American Journal of Managed Care
- Vol. 27 (12) , 524-530
Variation in early diffusion of sacubitril/valsartan and implications for understanding novel drug diffusion
Rates of sacubitril/valsartan diffusion have been slow and there has been significant geographic variation, highlighting the importance of local prescribing patterns in early drug diffusion.
- 1 December 2021
- Published by Clinical Care Targeted Communications Group, LLC in The American Journal of Managed Care
- Vol. 27 (12) , 524-530
Variation in early diffusion of sacubitril/valsartan and implications for understanding novel drug diffusion
Rates of sacubitril/valsartan diffusion have been slow and there has been significant geographic variation, highlighting the importance of local prescribing patterns in early drug diffusion.
- Open Access
- 9 October 2021
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 70 (1) , 306-307
Reply to: Comment on: The association between neurohormonal therapy and mortality in older adults with HFrEF
This letter comments on the letter by Gwen Thomas et al. in this issue.
- 9 October 2021
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 70 (1) , 306-307
Open AccessReply to: Comment on: The association between neurohormonal therapy and mortality in older adults with HFrEF
This letter comments on the letter by Gwen Thomas et al. in this issue.
- Open Access
- 17 August 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (16) , e020668
Association Between Diagnosis Code Expansion and Changes in 30‐Day Risk‐Adjusted Outcomes for Cardiovascular Diseases
BACKGROUND: In January 2011, Centers for Medicare and Medicaid Services expanded the number of inpatient diagnosis codes from 9 to 25, which may influence comorbidity counts and risk‐adjusted outcome rates for studies spanning January 2011. This study examines the association between (1) limiting versus not limiting diagnosis codes after 2011, (2) using inpatient‐only versus inpatient and outpatient data, and (3) using logistic regression versus the Centers for Medicare and Medicaid Services risk‐standardized methodology and changes in risk‐adjusted outcomes. METHODS AND RESULTS: Using 100% Medicare inpatient and outpatient files between January 2009 and December 2013, we created 2 cohorts of fee‐for‐service beneficiaries aged ≥65 years. The acute myocardial infarction cohort and the heart failure cohort had 578 728 and 1 595 069 hospitalizations, respectively. We calculate comorbidities using (1) inpatient‐only limited diagnoses, (2) inpatient‐only unlimited diagnoses, (3) inpatient and outpatient limited diagnoses, and (4) inpatient and outpatient unlimited diagnoses. Across both cohorts, International Classification of Diseases, Ninth Revision ( ICD‐9 ) diagnoses and hierarchical condition categories increased after 2011. When outpatient data were included, there were no significant differences in risk‐adjusted readmission rates using logistic regression or the Centers for Medicare and Medicaid Services risk standardization. A difference‐in‐differences analysis of risk‐adjusted readmission trends before versus after 2011 found that no significant differences between limited and unlimited models for either cohort. CONCLUSIONS: For studies that span 2011, researchers should consider limiting the number of inpatient diagnosis codes to 9 and/or including outpatient data to minimize the impact of the code expansion on comorbidity counts. However, the 2011 code expansion does not appear to significantly affect risk‐adjusted readmission rate estimates using either logistic or risk‐standardization models or when using or excluding outpatient data.
- 17 August 2021
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 10 (16) , e020668
Open AccessAssociation Between Diagnosis Code Expansion and Changes in 30‐Day Risk‐Adjusted Outcomes for Cardiovascular Diseases
BACKGROUND: In January 2011, Centers for Medicare and Medicaid Services expanded the number of inpatient diagnosis codes from 9 to 25, which may influence comorbidity counts and risk‐adjusted outcome rates for studies spanning January 2011. This study examines the association between (1) limiting versus not limiting diagnosis codes after 2011, (2) using inpatient‐only versus inpatient and outpatient data, and (3) using logistic regression versus the Centers for Medicare and Medicaid Services risk‐standardized methodology and changes in risk‐adjusted outcomes. METHODS AND RESULTS: Using 100% Medicare inpatient and outpatient files between January 2009 and December 2013, we created 2 cohorts of fee‐for‐service beneficiaries aged ≥65 years. The acute myocardial infarction cohort and the heart failure cohort had 578 728 and 1 595 069 hospitalizations, respectively. We calculate comorbidities using (1) inpatient‐only limited diagnoses, (2) inpatient‐only unlimited diagnoses, (3) inpatient and outpatient limited diagnoses, and (4) inpatient and outpatient unlimited diagnoses. Across both cohorts, International Classification of Diseases, Ninth Revision ( ICD‐9 ) diagnoses and hierarchical condition categories increased after 2011. When outpatient data were included, there were no significant differences in risk‐adjusted readmission rates using logistic regression or the Centers for Medicare and Medicaid Services risk standardization. A difference‐in‐differences analysis of risk‐adjusted readmission trends before versus after 2011 found that no significant differences between limited and unlimited models for either cohort. CONCLUSIONS: For studies that span 2011, researchers should consider limiting the number of inpatient diagnosis codes to 9 and/or including outpatient data to minimize the impact of the code expansion on comorbidity counts. However, the 2011 code expansion does not appear to significantly affect risk‐adjusted readmission rate estimates using either logistic or risk‐standardization models or when using or excluding outpatient data.
- 27 July 2021
- Published by Wolters Kluwer Health in Circulation
- Vol. 144 (4) , 283-285
Is Rising Cardiovascular Spending a Good News or Bad News Story?
- 27 July 2021
- Published by Wolters Kluwer Health in Circulation
- Vol. 144 (4) , 283-285
Is Rising Cardiovascular Spending a Good News or Bad News Story?